There is ample evidence for this in humans where hypermethylation in the promoter region of GSTP1 results in reduced GSTP1 expression affecting hepatocellular, breast, renal, lung, and colon cancer, as well as some lymphomas [35], [48], [49]. Here, GSTP1 is linked to lymphoma.